Streetbeat News

Analyst Ratings

COST

Baird analyst Peter Benedict has maintained an Outperform rating on Costco Wholesale (NASDAQ:COST) and increased the price target from $775 to $850.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:19 pm

COOK

Baird analyst Peter Benedict has maintained a Neutral rating on Traeger (NYSE:COOK) and reduced the price target from $3.5 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:18 pm

DOCU

Evercore ISI Group analyst Kirk Materne maintains an In-Line rating on DocuSign (NASDAQ:DOCU) and raises the price target from $55 to $60.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:17 pm

UNCY

HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating on Unicycive Therapeutics (NASDAQ:UNCY), maintaining a price target of $4.5.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:16 pm

HG

Wells Fargo analyst Elyse Greenspan maintains an Equal-Weight rating on Hamilton Insurance Group (NYSE:HG) and lowers the price target from $17 to $16.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:15 pm

BURL

Baird analyst Mark Altschwager maintains an Outperform rating on Burlington Stores (BURL) and raises the price target from $235 to $260.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:13 pm

AVGO

MRVL

QQQ

SPY

U.S. stock futures dipped ahead of a crucial jobs report, with a cautious sentiment prevailing despite recent gains. Technology stocks, especially chipmakers like Marvell Technology and Broadcom, reacted to their earnings. The S&P 500 and Nasdaq showed positive momentum in the previous session, buoyed by expectations of a Fed rate cut. Analysts remain optimistic about the market's outlook, especially after Super Tuesday, citing historical election year trends. In premarket trading, several stocks moved on earnings reports, including BigBear.ai, Broadcom, and Costco.

Portfolio Pulse from Shanthi Rexaline

March 08, 2024 | 12:12 pm

RVMD

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Revolution Medicines (NASDAQ:RVMD) and increased the price target from $28 to $44. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:12 pm

AVGO

Jefferies analyst Vedvati Shrotre maintains a Buy rating on Broadcom (NASDAQ:AVGO) and raises the price target from $1035 to $1616.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:12 pm

MDB

Mizuho analyst Matthew Broome maintains a Neutral rating on MongoDB (NASDAQ:MDB) and lowers the price target from $420 to $380.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:10 pm